Tel Aviv University Professor Itzhak Fried has completed his study of how memory neurons behave in real time. These have important implications for understanding dementia such as Alzheimer’s, and Israeli Moni Milchman developed ArchimedicX, the world’s first search engine for information about hospitals.
By: Michael Ordman
ISRAEL’S MEDICAL ACHIEVEMENTS
Watching memory at work
Tel Aviv University Professor Itzhak Fried has completed his study of how memory neurons behave in real time when they are “remembering.” He will present his findings at an upcoming Jerusalem symposium. These have important implications for understanding dementia such as Alzheimer’s.
http://www.timesofisrael.com/doh-how-homer-simpson-helps-researchers-understand-memory/
Hospital search engine wows Russia
Russia’s most dominant email service Mail.Ru is integrating the database of Archimedicx. Health Mail.Ru is one of the most popular health portals in Russia. Israeli Moni Milchman developed ArchimedicX, the world’s first search engine for information about hospitals.
http://www.geektime.com/2016/02/16/belgian-israeli-archimedicx-to-feature-its-listings-on-russian-mail-ru/
Breakthrough leukemia cure is “Israeli”
I was suspicious of the BBC’s report on the “innovative” US immunotherapy that cured 27 of 29 “no-hope” leukemia patients. Sure enough, the genetic modification of T-cells was developed by Weizmann Institute Professor Zelig Eshhar, and the US researchers accredited him.
http://www.timesofisrael.com/breakthrough-cancer-cure-has-deep-israeli-roots/#.VsSHARjfTx8.email
Positive trials for treatment of Graft vs Host disease
Israel’s Kamada has reported positive interim results from a Phase 1/2 clinical trial of its proprietary alpha-1 antitrypsin (AAT) to treat steroid-refractory Graft Versus Host Disease (GvHD). Subjects responded well to treatment in the small study.
http://www.kamada.com/news_item.php?ID=217
Patent for kidney cancer test
Israeli biotech Rosetta Genomics has been granted a US patent for its gene signature method of distinguishing four different types of kidney cancer. The molecular diagnostic test recognizes the profile of 29 microRNAs that are expressed in patients with renal cancer.
http://www.rosettagx.com/files/press_releases/2016/012516_ROSG_Kidney_Tumor_Classification_Patent_FINAL.pdf
ReWalk is medically necessary
A US surgeon, confined to a wheelchair following a spinal cord injury, has successfully won his case to be reimbursed by his health plan for a ReWalk exoskeleton. The ruling will help make ReWalk available to all eligible patients.
Israel-California biotech agreement
Israeli Science, Technology and Space Minister Ofir Akunis signed a biotechnology agreement with the California Institute for Regenerative Medicine (CIRM) Its focus is stem cell research and breakthroughs in treating diseases such as cancer, diabetes, Alzheimer’s and HIV-AIDS.
http://www.jns.org/news-briefs/2016/2/10/israel-and-california-sign-biotech-deal-with-emphasis-on-stem-cell-research
Click here for all of this week’s Good News from Israel.
